Vascular malformations are birth defects that happen when different stages of angiogenesis shut down. 44 - 64% of all vascular malformations are venous malformations (VMs). Sclerotherapy is the first treatment line for VMs. It acts by getting rid of the vascular endothelial cells in the lesion. One of the most common and well researched sclerosing agents for VMs is polidocanol, which is a popular counterpart for concentrated ethanol.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Heaviness questionnaire
Timeframe: 6 months post operative
Disfigurement questionnaire
Timeframe: 6 months post operative
size of venous malformation
Timeframe: 6 months post operative
Degree of satisfaction
Timeframe: 6 months post operative